• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.

作者信息

Avellone G, Di Garbo V, Cordova R, Raneli G, De Simone R, Bompiani G D

机构信息

Institute of Clinical Medicine, University of Palermo, Italy.

出版信息

Blood Coagul Fibrinolysis. 1993 Jun;4(3):429-33. doi: 10.1097/00001721-199306000-00006.

DOI:10.1097/00001721-199306000-00006
PMID:8329569
Abstract

We have measured various fibrinolytic and coagulation parameters (t-PA antigen, PAI, fibrinogen, plasminogen and factor VII) before and after 10 min of venous occlusion in 20 hypertryglyceridaemic subjects (twelve males and eight females, age 38 +/- 4 years, body mass index 23 +/- 1.5) and 20 healthy normal subjects, matched for sex (twelve males and eight females), age (37 +/- 3.5 years) and body mass index (22.8 +/- 1.4). At rest, t-PA:Ag, PAI, fibrinogen, plasminogen and factor VII were significantly (P < 0.005) higher in hypertriglyceridaemic subjects than in normal controls. After venous occlusion, the increase in all parameters except t-PA:Ag was more marked in the patient group than in the controls. Only the percentage increase in t-PA:Ag was higher in normal controls (358.8%) than in hypertriglyceridaemic subjects (91.9%). There was a positive correlation between serum triglycerides levels and PAI at rest (r = 0.72, P < 0.01) and a negative correlation between serum triglycerides levels and t-PA antigen after venous occlusion (r = -0.45, P < 0.05) suggesting an impairment of fibrinolysis in hypertriglyceridaemia.

摘要

相似文献

1
Fibrinolysis in hypertriglyceridaemic subjects in response to venous occlusion.
Blood Coagul Fibrinolysis. 1993 Jun;4(3):429-33. doi: 10.1097/00001721-199306000-00006.
2
Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis.老年人血脂相关的止血异常:凝血与纤溶之间的失衡
Atherosclerosis. 1993 Nov;103(2):131-8. doi: 10.1016/0021-9150(93)90256-t.
3
[Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].[长期血液透析患者静脉闭塞后的纤维蛋白溶解功能减退]
Cas Lek Cesk. 1994 May 30;133(11):346-9.
4
Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.青少年血液纤溶成分的年龄依赖性以及低剂量口服避孕药对青少年凝血和纤溶的影响。
Thromb Haemost. 1988 Dec 22;60(3):361-4.
5
The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state.
Blood Coagul Fibrinolysis. 1992 Dec;3(6):789-93. doi: 10.1097/00001721-199212000-00013.
6
Blood coagulation and fibrinolysis in obese NIDDM patients.肥胖型非胰岛素依赖型糖尿病患者的血液凝固与纤维蛋白溶解
Diabetes Res. 1994;25(2):85-92.
7
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.纤维蛋白原、凝血因子VII、组织型纤溶酶原激活剂、纤溶酶原激活剂抑制剂-1以及脂质作为慢性血液透析和持续性非卧床腹膜透析患者的心血管危险因素。
Am J Kidney Dis. 1996 Jun;27(6):848-54. doi: 10.1016/s0272-6386(96)90523-5.
8
Improvement of fibrinolysis and plasma lipoprotein levels induced by gemfibrozil in hypertriglyceridemia.
Blood Coagul Fibrinolysis. 1995 Sep;6(6):543-8. doi: 10.1097/00001721-199509000-00007.
9
Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.健康受试者对静脉闭塞的纤溶反应的可重复性。
Thromb Haemost. 1995 Mar;73(3):453-7.
10
Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.有特发性深静脉血栓形成和/或肺栓塞病史患者的纤溶功能减退。
Thromb Haemost. 1992 Apr 2;67(4):397-401.

引用本文的文献

1
The role of hypertriglyceridemia in atherosclerosis.高甘油三酯血症在动脉粥样硬化中的作用。
Curr Atheroscler Rep. 2007 Aug;9(2):110-5. doi: 10.1007/s11883-007-0006-7.
2
Hypertriglyceridemia-why, when and how should it be treated?高甘油三酯血症——为何、何时以及如何进行治疗?
Z Kardiol. 2005 Nov;94(11):731-9. doi: 10.1007/s00392-005-0295-1.